NOTE AMENDMENTNote Amendment • September 13th, 2022 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
This Note Amendment dated as of September 6, 2022 (the “Agreement”) is by and between Volcon, Inc., a Delaware corporation (the “Company”), and the undersigned, a Holder of Notes (as defined below) identified on the signature pages hereto. Capitalized terms not defined herein shall have the meanings assigned to them in those certain Senior Convertible Notes dated as of August 24, 2022 (the “Notes”) issued by the Company to the undersigned and other holders thereof.
FORM OF NOTE AMENDMENTNote Amendment • January 3rd, 2014 • Axion Power International, Inc. • Miscellaneous electrical machinery, equipment & supplies
This Note Amendment (the “Amendment”) is dated as of this 2nd day of January, 2014 by and between Axion Power International, Inc., as Borrower (the “Company”) and ______, as Lender (the “Lender”).
NOTE AMENDMENTNote Amendment • August 14th, 2014 • California Gold Corp. • Metal mining • New York
This Amendment, dated as of ___________ 2014 (this “Amendment”), by and between California Gold Corp. (the “Company”) and the investor set forth on the signature page hereto (the “Noteholder”), has been executed for the purpose of amending that certain 10% Convertible Promissory Note issued by the Company to the Noteholder on February 7, 2014 and/or March 3, 2014, as applicable (each, a “Note”).
NOTE AMENDMENTNote Amendment • September 15th, 2023 • Volcon, Inc. • Motor vehicles & passenger car bodies • New York
This Note Amendment dated as of September 14, 2023 (the “Agreement”) is by and between Volcon, Inc., a Delaware corporation (the “Company”), and the undersigned, a Holder of Notes (as defined below) identified on the signature pages hereto. Capitalized terms not defined herein shall have the meanings assigned to them in that certain (i) Securities Purchase and Exchange Agreement (the “SPA”) dated as of May 19, 2023 by and among the Company and each purchaser identified on the signature pages thereto (each, a “Purchaser” and collectively, the “Purchasers”); (ii) the amended and restated Original Issue Discount Senior Convertible Series A Notes and the amended and restated Original Issue Discount Senior Convertible Series B Notes dated as of May 24, 2023 (collectively, the “Amended and Restated Notes”) issued by the Company to each Purchaser; and (iii) the new Original Issue Discount Senior Convertible Notes dated as of May 24, 2023 (the “New Notes” and with the Amended and Restated Note
NOTE AMENDMENTNote Amendment • December 28th, 2023 • Velo3D, Inc. • Special industry machinery, nec • Delaware
This NOTE AMENDMENT, dated as of December 27, 2023 (this “Agreement”), is entered into between Velo3D, Inc., a Delaware corporation (the “Company”), the undersigned holder (“Holder 1”) of that Senior Secured Note due 2026, Certificate No. A-2, issued by the Company on November 28, 2023 in the principal amount of thirty-four million five hundred thousand dollars ($34,500,000) (the “Holder 1 Note”), the undersigned holder (“Holder 2” and, together with Holder 1, the “Note Holders”) of that Senior Secured Note due 2026, Certificate No. A-1, issued by the Company on November 28, 2023 in the principal amount of twenty-three million dollars ($23,000,000) (the “Holder 2 Note” and together with the Holder 1 Note, the “Notes”) and acknowledged by U.S. Bank Trust Company, as trustee (the “Trustee”).
NOTE AMENDMENTNote Amendment • February 12th, 2010 • Global Telecom & Technology, Inc. • Telephone communications (no radiotelephone) • Virginia
This NOTE AMENDMENT (this “Amendment”) is entered into as of the Effective Date (as defined below) by and among Global Telecom & Technology, Inc. (the “Company”) and the holders (“Holders”) of the Company’s 10% convertible subordinated notes due on December 31, 2010 issued November 2007 (the “Notes”).
NOTE AMENDMENTNote Amendment • July 21st, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Note Amendment (this “Amendment”) is made as of this 20th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders (each a “Holder”) of an unsecured promissory note issued pursuant to the terms of that certain Note and Warrant Purchase Agreement dated June 11, 2009 (“Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes.
